Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
XTSX:IPA
Price:
6.5 CAD
0.78%
Updated:
May 10, 2024
Immunoprecise Antibodies Ltd
EPS (Diluted)
|
Immunoprecise Antibodies Ltd
EPS (Diluted) Peer Comparison
Comparables:
ABCL
ARCH
RP
IOT
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Arch Biopartners Inc
XTSX:ARCH
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
14%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Replicel Life Sciences Inc
XTSX:RP
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-16%
|
|
|
Innovotech Inc
XTSX:IOT
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Immunoprecise Antibodies Ltd's EPS (Diluted)?
EPS (Diluted)
-0.5
CAD
-0.5
CAD
Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's EPS (Diluted) amounts to -0.5 CAD.
What is Immunoprecise Antibodies Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
8%
8%
Over the last year, the EPS (Diluted) growth was -25%. The average annual EPS (Diluted) growth rates for Immunoprecise Antibodies Ltd have been 8% over the past three years .
You don't have any saved screeners yet
